Nachman Norwood & Parrott’s Medpace MEDP Stock Holding History

Nachman Norwood & Parrott’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-27	Closed	-$3K	–	715
2020 Q3	$3K	Buy	+27	New	+$3.12K	﹤0.01%	1044

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nachman Norwood & Parrott's MEDP Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Medpace (MEDP) in Q4 2020, closing a stake of 27 shares — an estimated $3K sold.

Nachman Norwood & Parrott first reported a position in MEDP in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 316 funds tracked by Wall St. Rank hold MEDP as of Q4 2020.

Nachman Norwood & Parrott reported no remaining Medpace position as of Q4 2020 after selling out during the quarter.
Nachman Norwood & Parrott sold 27 Medpace shares in Q4 2020, an estimated $3K.
Nachman Norwood & Parrott first reported a position in Medpace in Q3 2020 and held it in 1 quarter.
Nachman Norwood & Parrott's Medpace position peaked at $3K in Q3 2020.
316 funds tracked by Wall St. Rank held Medpace as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.